Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: A multigenic assessment

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Pankratz, V Shane ^a   Vierkant, Robert A ^a   O'Byrne, Megan M ^a   Ovsyannikova, Inna G ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; MEASLES MUMPS RUBELLA VACCINE; RUBELLA ANTIBODY; FUCOSE BINDING LECTIN; FUCOSE-BINDING LECTIN; LECTIN; RUBELLA ANTIBODIES; VIRUS ANTIBODY;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE ISOLATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE GENE; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; RUBELLA; SINGLE NUCLEOTIDE POLYMORPHISM; BIOSYNTHESIS; BLOOD; CHILD; GENETICS; IMMUNOLOGY; POPULATION; VACCINATION;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; GENETIC ASSOCIATION STUDIES; HUMANS; INTERLEUKIN-6; LECTINS; MEASLES-MUMPS-RUBELLA VACCINE; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION; RECEPTORS, INTERLEUKIN-4; RUBELLA; VACCINATION;

EID: 77957268834     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-48     Document Type: Article

References (48)

1. Best JM, Castillo-Solorzano C, Spika JS, Icenogle J, Glasser JW, Gay NJ, Andrus J, Arvin AM. Reducing the Global Burden of Congenital Rubella Syndrome: Report of the World Health Organization Steering Committee on Research Related to Measles and Rubella Vaccines and Vaccination, June 2004. J Infect Dis 2005, 192:1890-7. 10.1086/497607, 16267759.
2. Novo A, Huebschen JM, Muller CP, Tesanovic M, Bojanic J. Ongoing rubella outbreak in Bosnia and Herzegovina, March-July 2009--preliminary report. Euro Surveill 2009, 14:19343.
3. Tan P-L, Jacobson RM, Poland GA, Jacobsen SJ, Pankratz VS. Twin studies of immunogenicity - determining the genetic contribution to vaccine failure. Vaccine 2001, 19:2434-2439. 10.1016/S0264-410X(00)00468-0, 11257374.
4. Kato S, Kimura M, Takakura I, Sakakibara T, Inouye H, Tsuji K. Possible associations between HLA antigens and the immune responsiveness to attenuated rubella vaccine. Tissue Antigens 1978, 11:475-478. 10.1111/j.1399-0039.1978.tb01287.x, 99841.
5. Ovsyannikova IG, Jacobson RM, Ryan JE, Dhiman N, Vierkant RA, Poland GA. Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination. Clin Vaccine Immunol 2007, 14:115-122. 10.1128/CVI.00247-06, 1797784, 17215337.
6. Ou D, Mitchell LA, Décarie D, Tingle AJ, Nepom GT. Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype. Hum Immunol 1998, 59:149-157. 10.1016/S0198-8859(98)00006-8, 9548074.
7. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 2004, 65:1506-1515. 10.1016/j.humimm.2004.07.001, 15603879.
8. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis 2005, 191:515-519. 10.1086/427558, 15655774.
9. Ovsyannikova IG, Jacobson RM, Vierkant RA, O'Byrne MM, Poland GA. Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine 2009, 27:6926-31. 10.1016/j.vaccine.2009.08.109, 19761839.
10. Ovsyannikova IG, Dhiman N, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA. Rubella vaccine-induced cellular immunity: Evidence of associations with polymorphisms in the Toll-like, Vitamin A and D receptors and innate immune response genes. Hum Genet 2010, 127:207-221. 10.1007/s00439-009-0763-1, 19902255.
11. Ovsyannikova IG, Haralambieva IH, Dhiman N, O'Byrne MM, Pankratz VS, Jacobson RM, Poland GA. Polymorphisms in the vitamin a receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis 2010, 201:207-213. 10.1086/649588, 20001730.
12. Dhiman N, Ovsyannikova I, Vierkant R, Pankratz VS, Jacobson R, Poland GA. Associations between cytokine/cytokine receptor SNPs and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 2008, 72:211-220. 10.1111/j.1399-0039.2008.01097.x, 2595143, 18715339.
13. Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA. Human Leukocyte Antigen Haplotypes in the Genetic Control of Immune Response to Measles-Mumps-Rubella Vaccine. J Infect Dis 2006, 193:655-663. 10.1086/500144, 16453260.
14. Kennedy RB, Ovsyannikova IG, Vierkant RA, Jacobson RM, Poland GA. Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses. Hum Immunol 2010, 71:128-135. 10.1016/j.humimm.2009.11.002, 19896518.
15. Haralambieva IH, Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. 2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Human Immunology 2010, 71:383-391. 10.1016/j.humimm.2010.01.004, 20079393.
16. Dhiman N, Haralambieva IH, Kennedy RB, Vierkant RA, O'Byrne MM, Ovsyannikova IG, Jacobson RM, Poland GA. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccination. Immunogenetics 2010, 62:197-210. 10.1007/s00251-010-0423-6, 20217072.
17. Dhiman N, Ovsyannikova IG, Cunningham JM, Vierkant RA, Kennedy RB, Pankratz VS, Poland GA, Jacobson RM. Associations between measles vaccine immunity and single nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007, 195:21-29. 10.1086/510596, 17152005.
18. Ovsyannikova IG, Jacobson RM, Dhiman N, Vierkant RA, Pankratz VS, Poland GA. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics 2008, 121:e1091-e1099. 10.1542/peds.2007-1575, 2668976, 18450852.
19. van Deventer SJH. Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med 2000, 26(Suppl 1):S98-S102. 10.1007/s001340051125, 10786965.
20. Haukim N, Bidwell JL, Smith AJP, Keen LJ, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, et al. Cytokine gene polymorphism in human disease: on-line databases, Supplement 2. Genes and Immunity 2002, 3:313-330. 10.1038/sj.gene.6363881, 12209358.
21. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998, 16:593-617. 10.1146/annurev.immunol.16.1.593, 9597143.
22. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773. 10.1126/science.1123933, 16497887.
23. Bochud PY, Bochud M, Telentim A, Calandra T. Innate immunogenetics: a tool for exploring new frontiers of host defence. Lancet Infect Dis 2007, 7:531-542. 10.1016/S1473-3099(07)70185-8, 17646026.
24. MacKichan ML. Toll bridge to immunity. Immune molecules hold promise for vaccine adjuvant discovery. IAVI Rep 2005, 9:1-5.
25. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008, 8:685-698. 10.1038/nri2378, 2906676, 19172691.
26. Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: The role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 2007, 82:653-664. 10.1038/sj.clpt.6100415, 17971814.
27. Trowsdale J, Parham P. Mini-review: defense strategies and immunity-related genes. Eur J Immunol 2004, 34:7-17. 10.1002/eji.200324693, 14971025.
28. Petranyi GG. The complexity of immune and alloimmune response. Transpl Immunol 2002, 10:91-100. 10.1016/S0966-3274(02)00054-0, 12216955.
29. Motsinger AA, Haas DW, Hulgan T, Ritchie MD. Human genomic association studies: A primer for the infectious diseases specialist. J Infect Dis 2007, 195:1737-1744. 10.1086/518247, 17492588.
30. Gibson G. Epistasis and pleiotropy as natural properties of transcriptional regulation. Theor Popul Biol 1996, 49:58-89. 10.1006/tpbi.1996.0003, 8813014.
31. Thornton-Wells TA, Moore JH, Haines JL. Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet 2004, 20:640-647. 10.1016/j.tig.2004.09.007, 15522460.
32. Hoh J, Wille A, Ott J. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Research 2001, 11:2115-2119. 10.1101/gr.204001, 311222, 11731502.
33. Nelson MR, Kardia SL, Ferrell RE, Sing CF. A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Research 2001, 11:458-470. 10.1101/gr.172901, 311041, 11230170.
34. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Multifactor dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001, 69:138-147. 10.1086/321276, 1226028, 11404819.
35. Millstein J, Conti DV, Gilliland FD, Gauderman WJ. A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet 2006, 78:15-27. 10.1086/498850, 1380213, 16385446.
36. Motsinger AA, Dudek SM, Hahn LW, Ritchie MD. Comparison of neural network optimization approaches for studies of human genetics. Lect Notes Comput Sci 2006, 3907:103-104. full_text, 2828685, 20191104.
37. Schaid DJ, McDonnell SK, Hebbring SJ, Cunningham JM, Thibodeau SN. Nonparametric tests of association of multiple genes with human disease. Am J Hum Genet 2005, 76:780-793. 10.1086/429838, 1199368, 15786018.
38. Marchini J, Donnelly P, Cardon LR. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nature Genet 2005, 37:413-417. 10.1038/ng1537, 15793588.
39. Manly BFJ. Randomization, Bootstrap and Monte Carlo Methods in Biology. 1997, Boca Raton, FL: Chapman & Hall/CRC, 2.
40. Ovsyannikova IG, Ryan JE, Vierkant RA, O'Byrne MM, Pankratz VS, Jacobson RM, Poland GA. Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination. Vaccine 2009, 27:3359-3366. 10.1016/j.vaccine.2009.01.079, 2693348, 19200845.
41. The International HapMap Project. City
42. SeattleSNPs Variation Discovery Resource. City
43. National Institute of Environmental Health Sciences Environmental Genome Project: NIEHS SNPs.
44. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004, 74:106-120. 10.1086/381000, 1181897, 14681826.
45. den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations. Hum Genet 2001, 109:121-124. 10.1007/s004390100505, 11479744.
46. Weir B. Genetic data Analysis II: methods for discrete population genetic data. 1996, 98-99. Sunderland, MA: Sinauer Associates, Inc.
47. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. 1983, Belmont, CA: Wadsworth.
48. Clark LA, Pregibon D. Tree-based models. Statistical Models in S 1992, Pacific Grove, CA: Wadsworth and Brooks/Cole, Chambers JM, Hastie TJ.